Please login to the form below

Double Communiqué award win for 90TEN

6 July 2015, London – 90TEN was recognised with two award wins at last week’s Communique Awards and was shortlisted with a further three awards.

The consultancy’s campaign for Novartis in chronic spontaneous urticaria won the Excellence in the Communications of Survey or Market Research Data award, while its work with Allergan in migraine won the Excellence in Communications via a Live Event or Stand-Alone Activity award.  

Paul Tanner, chairman and co-founder of 90TEN said: “These two creative programmes demonstrate that 90TEN’s behaviour change methodology is driving measurable improvements in health outcomes. With a 13-year heritage of delivering behaviour change across PR, medical education and medication adherence programmes, 90TEN is proud to be recognised for its life changing work.”  

Despite affecting up to 500,000 Britons and having a major impact on quality of life, chronic spon­taneous urticaria (CSU) – a type of severe hives – was, until recently, a mystery to many doctors and almost completely unknown to the general public. 90TEN and IPG created the Wheals of Despair programme, which took the real-life stories of people living with CSU alongside insights from Allergy UK and health professionals to create a compelling patient resource and a hard-hitting campaign full of ‘firsts’, including the first ever mention of CSU in Parliament.  

Commenting on Wheals of Despair, the Communiqué judges said: “This was a fantastic and integrated campaign with a solid execution that really has delivered for patients by exposing their misery. Wheals of Despair really highlights the unmet need of this little known condition and has made a real difference for sufferers.”   

Migraine is an incredibly disabling condition, with the World Health Organization comparing the impact of a severe episode to that of someone with paralysis from the neck down. The Migraine Unlocked campaign took a surround-sound communications approach using advertising, media and grassroots campaigning to maximise exposure to sufferers and their loved ones. This was combined with access to headache specialists who were there to motivate them into action.  

Commenting on Migraine Unlocked, the Communiqué judges said: “We just loved the outcomes of this campaign. It took the message to people in an incredibly compelling way.”

-  ends  -  

Contact
Paul Tanner, 90TEN – paul.tanner@90ten.co.uk – +44(0)79 0067 3376
 

About 90TEN Healthcare
 
90TEN is a global, independent healthcare communications consultancy that delivers communications programmes which engage people and change behaviours – helping to enhance clinical practice and improve patient outcomes.

8th July 2015

Share

Company Details

90TEN

+44 (0)20 7627 0990

Contact Website

Address:
Battersea Studios
80 Silverthorne Road
London
SW8 3HE
UK

Latest content on this profile

Award-winning health agency 90TEN launches in the US
Agency veteran Kate Paxton appointed to lead operation, bringing nearly 30 years of global and US biopharma experience.
90TEN
90TEN promotes Claire Long and Sabrina Gomersall to lead Communications division
Senior leadership team further bolstered by appointment of Rick Evans to the newly created role of Social Strategy Director
90TEN
90TEN seeks US Head to lead expansion of its PR division in the region
90TEN is seeking an ambitious and driven healthcare communicator to lead the expansion of its award-winning public relations division into the US.
90TEN
90TEN strengthens senior management team to enhance behavioural science and creative services
90TEN announces the establishment of a new role of Head of Behavioural Sciences along with three promotions within the senior management team and two new hires, enhancing the company’s behavioural science and creative capabilities.
90TEN
90TEN Chemistry

90TEN
We are 90TEN

90TEN